Thomas Blaettler

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial”.

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2023)10.1016/s1474-4422(23)00275-2

N/A

0.867DataRank · unranked

34 citations

Michael McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A. Amato, Emma Ciafaloni +74 more

The Early History of Arimoclomol for Inclusion Body Myositis

RRNMF Neuromuscular Journal(2021)10.17161/rrnmf.v2i2.15404

N/A

0DataRank · unranked

2 citations

Pedro Machado, Claus Sundgreen, Thomas Blaettler, Jeffery Statland, Andrew Heim +4 more